*By Carlo Versano*
The world's largest beverage maker is reportedly eyeing the red-hot cannabis market, according to a [report] (https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528).
Coca-Cola is in "serious talks" with Aurora Cannabis to develop cannabidiol-infused beverages, according to BNN Bloomberg.
A deal on that scale would likely dwarf agreements made by Corona-maker Constellation Brands and Molson Coors, both of which have partnered with Canadian cannabis companies to add CBD, the non-psychoactive ingredient in cannabis that can be used to treat pain or anxiety, to drinks like coffee, soda, and beer, and would represent a "mainstreaming" of pot products in the eyes of Wall Street.
For Coke, getting into the weed market would be both capturing a trend and a diversification play. Soda sales have been down as younger consumers seek out healthier drinks like sparkling water.
Shares of Aurora were up over 6 percent on the news Monday morning, as were other pot stocks like Tilray.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
